Pharmaceutical Status

NAMSA Europe have received pharmaceutical status by AFSSAPS, this is the result of their ongoing investment and improvement program which allows them to offer competitive release pyrogen testing.

Help is at hand with NAMSA Europe who now offers regulatory coaching.

This service is provided by NAMSA's top scientists, many of whom sit on international regulatory committees, and is available as fully-fledged consulting or as telephone support.

Areas covered include MHRA and FDA submissions as well as applications for European funding and reimbursement.

Pharmaceutical status for NAMSA Europe expands testing capability NAMSA Europe have received "pharmaceutical status" by French AFSSAPS.

This prestigious award is the result of their ongoing investment and improvement program and allows us to offer competitive release pyrogen testing to the pharmaceutical and biotech industry.

In addition, we also offer pharmacokinetics and rapid start of early-stage drug safety assessment of active compounds.

Two new major toxicology facilities increase global testing capacity NAMSA's Ohio and French operations now respectively boast 4180 and 1393 sq.

metre of brand new state-of-the-art laboratory facilities.

NAMSA now offers an even greater range of testing services including small and large model R and D studies, functionality and performance, material characterization, biocompatibility and histopathology.

Modern surgical suites also support these facilities.

Back to top